BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

LifeScience

Can APAC Biomanufacturing Decarbonise Without Pricing Itself Out?

Scope 3 clauses, single-use plastic, water and energy intensity: the “green premium” has become the defining question for the CDMOs that built ...

July 14, 2026 | Analysis

QIAGEN Expands Philippines Presence with Experience Lab and Strategic Distribution Partnership

Partnership with Hamburg Trading Corp to advance applied testing and life science research Serving as a learning hub to empower the next generatio...

July 10, 2026 | News

LG Chem and OTR Therapeutics Partner to Advance China-Sourced Oncology Assets Globally

OTR Therapeutics, a clinical-stage biotechnology company dedicated to transforming early-stage innovations into globally impactful therapies, today an...

July 09, 2026 | News

After the Rush: APAC's mRNA and Vaccine Capacity Hangover

In June 2022, South Korea had something it had wanted for two years: a COVID-19 vaccine of its own. SKYCovione, developed by SK bioscience with the U...

July 08, 2026 | Analysis

Abbisko and AstraZeneca Partner to Advance Novel Oral IO-TKI Combination for EGFR-Mutant Lung Cancer

Abbisko Therapeutics Co., Ltd. ("Abbisko Therapeutics" hereafter, announced that it has entered into a strategic collaboration agreement with AstraZeneca (...

July 03, 2026 | News

Colossal Foundation and University of Tasmania Partner to Fight Deadly Tasmanian Devil Cancer with Gene Editing and Vaccines

The collaboration leverages Colossal's marsupial de-extinction and conservation biotechnology platform to save the Tasmanian devil from a contagious cancer...

July 01, 2026 | News

Can APAC Build Radioligand Therapy Before the Atoms Decay?

Every dose of radioligand therapy is a countdown. The moment a batch of lutetium-177 leaves the reactor, it begins to fade — roughly half its therape...

July 02, 2026 | Analysis

Everest Medicines' LEROCHOL® BLA Accepted in China for Third-Generation PCSK9 Inhibitor

Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing an...

June 29, 2026 | News

Merck Expands Life Science Leadership with Planned $11.3 Billion Bio-Techne Acquisition

Purchase price of US$73 per share in cash represents an enterprise value of US$11.3 billion (EUR 9.9 billion) Proposed acquisition expected to be immedi...

June 26, 2026 | News

Samsung Bioepis and ATLATL Launch Innovation Prize to Accelerate Asia-Pacific Biotech Startups

Applications Open June 25 for Early-Stage Biotech Companies Developing Next-Generation Therapeutics and Platform Technologies ATLATL Innovation Center ("A...

June 26, 2026 | News

Billions on Bioconjugation: Is APAC Building the Right ADC Capacity — or Too Much?

In Songdo, on the reclaimed waterfront west of Seoul, a 202,000-square-metre construction site is becoming the most expensive single statement Kore...

June 19, 2026 | Analysis

Simcere and Stanford Medicine Partner to Advance First-in-Class Therapy for Idiopathic Pulmonary Fibrosis

Simcere Pharmaceutical Group Limited (2096.HK) entered into a research collaboration agreement with Stanford Medicine to jointly advance an exploratory stu...

June 15, 2026 | News

SK Bioscience Licenses CDC Rotavirus Vaccine Technology to Advance Global Immunisation Efforts

SK bioscience licenses vaccine technology from the U.S. Centers for Disease Control and Prevention SK bioscience is jointly investing with t...

June 11, 2026 | News

PromptBio Launches Agentic AI Platform to Accelerate Scientific Discovery

The PromptBio Platform combines conversational AI with multi-agent orchestration to accelerate discovery from hypotheses to insights PromptBio, a Californ...

June 11, 2026 | News

Stay Connected